During the past decade, Gastroenterology Specialties, P.C. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gastroenterology Specialties, P.C." #1 collaborator was "RTI Health Solutions" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Gastroenterology Specialties, P.C." are "Crohn's Disease" (4 trials), "Irritable Bowel Syndrome" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "Gastroenterology Specialties, P.C." in a lesser frequency.

Most popular intervention types in "Gastroenterology Specialties, P.C." are "Drug" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Adalimumab (D2E7)" (1 trials), "Adalimumab 40 mg eow or ew" (1 trials), "Asimadoline" (1 trials), "DB adalimumab 40 mg eow" (1 trials) and "DB adalimumab 40 mg ew" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gastroenterology Specialties, P.C." are 6 trials for "All" genders.

Currently, there are NaN active trials in "Gastroenterology Specialties, P.C.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Gastroenterology Specialties, P.C., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gastroenterology Specialties, P.C., 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".